NCT04409860
- Conditions
- Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
- Locations
-
- Chongqing Cancer Hospital Chongqing, Chongqing Municipality, China
Clinical trial condition
Cervical Cancer
Explore clinical trials studying Cervical Cancer. Study availability and eligibility vary by location and protocol.
898 public trials
218 recruiting studies
Cervical Cancer trial results
NCT04403867
- Conditions
- Cervical Cancer, Cervical Neoplasm, Cervical Tumor, +27 more
- Locations
-
- Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy
NCT05367206
- Conditions
- Bulky Neoplasm, Cervical Cancer, Female Urogenital Diseases, +13 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdone, China
NCT04974346
- Conditions
- Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
- Locations
-
- Zhejiang Cancer Hospital Hangzhou, Zhejiang, China
- The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, China
- Jinhua Municipal Central Hospital Medical Group Jinhua, China
- Lishui People's Hospital Lishui, China
NCT04929769
- Conditions
- Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
- Locations
-
- The Obstetrics and Gynecology Hospital of Fudan University Shanghai, Shanghai Municipality, China
Recruiting
Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden
NCT04910802
- Conditions
- CIN 2/3, Cervical Cancer, Communicable Diseases, +24 more
- Locations
-
- Cancer prevention, screening, and counseling unit, Regional Cancer Center of Stockholm-Gotland Stockholm, Sweden
NCT04733820
- Conditions
- Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
- Locations
-
- Tongji Hospital Wuhan, Hubei, China
NCT03249519
- Conditions
- Body Temperature Changes, Cervical Cancer, Female Urogenital Diseases, +17 more
- Locations
-
- Universitätsklinikum Erlangen, Strahlenklinik Erlangen, Germany
Enrolling by Invitation
A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4
NCT07218003
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +54 more
- Locations
-
- UCSF Medical Center San Francisco, California, United States
- Yale Cancer Center New Haven, Connecticut, United States
- START Midwest Grand Rapids, Michigan, United States
- Memorial Sloan Kettering Cancer Center New York, United States
Enrolling by Invitation
Diagnostic Evaluation of Viral Persistence in Cervical Cancer
NCT07325682
- Conditions
- Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
- Locations
-
- City Branch of the National Oncology and Radiology Center Tashkent, Uzbekistan